Table 1.
Age, years | 66 (62–75) |
Sex, female, no. (%) | 2 (13) |
Height, cm | 175 (170–178) |
Body mass index, kg/m2 | 28 (24–30) |
SAPS II | 31 (29–37) |
SOFA at study inclusion | 2 (2–2) |
COVID-19 as the cause of respiratory failure | 10 (67) |
Hematological malignancies, no.(%) | 3 (20) |
Duration of Non-Invasive respiratory support before enrollment, hours | |
Non-Invasive Ventilation | 0 (0–0) |
Continuous Positive Airway Pressure | 0 (0–0) |
High Flow Nasal Oxygen | 0 (0–12) |
Bilateral infiltrates at study inclusion | 14 (93) |
PaO2/FiO2 during face mask O2 | 120 (103–137) |
PaCO2 during face mask O2 | 34 (27–36) |
Glasgow Coma Scale score on inclusion | 15 (15–15) |
Treatment failure after the enrollment – need for endotracheal intubation, no. (%) | 4 (27) |
Length of ICU stay, days | 13 (5–19) |
In-ICU mortality no. (%) | 6 (40) |
Data are reported as medians (Interquartile range), unless specified otherwise.